EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity

Fengwen Zhang, Fabian Schmidt, Frauke Muecksch, Zijun Wang, Anna Gazumyan, Michel C Nussenzweig iD, Christian Gaebler, Marina Caskey, Theodora Hatziioannou iD, Paul D Bieniasz iD

mBio · 14.02.2024 · 15 (2)

DOI: 10.1128/mbio.01672-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 14.02.2024. Verfasst von Fengwen Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The attachment of glycans to the spike proteins of viruses during their synthesis and movement through the secretory pathway can affect their properties. This study shows that the glycans attached to the severe acute respiratory syndrome coronavirus-2 spike protein enable its movement to the cell surface and incorporation into virus particles. Certain glycans, including one that is attached to asparagine 343 in the receptor-binding domain of the spike protein, can also affect virus neutralization by antibodies. This glycan can increase or decrease sensitivity to individual antibodies, likely through direct effects on antibody epitopes and modulation of spike conformation. However, the overall effect of the glycan in the context of the polyclonal mixture of antibodies in convalescent serum is to reduce neutralization sensitivity. Overall, this study highlights the complex effects of glycosylation on spike protein function and immune evasion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansSpike Glycoprotein, CoronavirusAntibodies, ViralGlycosylationCOVID-19 SerotherapyAntibodies, NeutralizingPolysaccharidesNeutralization Tests

Stichwörter der Autor:innen

SARS-CoV-2antibody functionglycosylationneutralization

Substanzen

Spike Glycoprotein, CoronavirusAntibodies, ViralAntibodies, NeutralizingPolysaccharidesspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA.

ORCID-Profile: Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Zhang, F., Schmidt, F., Muecksch, F., Wang, Z., Gazumyan, A., Nussenzweig, M. C., Gaebler, C., Caskey, M., Hatziioannou, T., & Bieniasz, P. D. (2024). SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity. mBio, 15(2). https://doi.org/10.1128/mbio.01672-23

Vancouver

Zhang F, Schmidt F, Muecksch F, Wang Z, Gazumyan A, Nussenzweig MC, et al. SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity. mBio. 2024;15(2). doi:10.1128/mbio.01672-23

BibTeX
@article{Zhang2024,
  author = {Zhang, Fengwen and Schmidt, Fabian and Muecksch, Frauke and Wang, Zijun and Gazumyan, Anna and Nussenzweig, Michel C and Gaebler, Christian and Caskey, Marina and Hatziioannou, Theodora and Bieniasz, Paul D},
  title = {SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity},
  journal = {mBio},
  year = {2024},
  volume = {15},
  number = {2},
  doi = {10.1128/mbio.01672-23}
}
Kostenlos starten →